Pharmacogenetics of new analgesics.

Abstract excerpt

Patient phenotypes in pharmacological pain treatment varies between individuals, which could be partly assigned to their genotypes regarding the targets of classical analgesics (OPRM1, PTGS2) or associated signalling pathways (KCNJ6). Translational and genetic research have identified new targets, for which new analgesics are being developed. This addresses voltage-gated sodium, calcium and potassium channels,...

Topics

Share this publication in a Topic to start or enrich a Post.

• Share to Analgesics
• Share to Ion Channels
• Share to Molecular Targeted Therapy